Rudy Li
Stock Analyst at Chardan Capital
(1.40)
# 3,332
Out of 4,869 analysts
17
Total ratings
47.06%
Success rate
-10.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PRTA Prothena Corporation | Maintains: Buy | $40 → $18 | $5.72 | +214.69% | 5 | May 27, 2025 | |
DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $27.31 | +192.93% | 2 | May 21, 2025 | |
XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $32.06 | +71.55% | 2 | May 13, 2025 | |
MNMD Mind Medicine (MindMed) | Maintains: Buy | $20 | $7.05 | +183.69% | 3 | May 9, 2025 | |
CNTA Centessa Pharmaceuticals | Initiates: Buy | $30 | $12.46 | +140.77% | 1 | May 8, 2025 | |
PRAX Praxis Precision Medicines | Initiates: Buy | $80 | $42.90 | +86.48% | 1 | May 7, 2025 | |
STOK Stoke Therapeutics | Maintains: Buy | $24 | $11.59 | +107.08% | 3 | Mar 19, 2025 |
Prothena Corporation
May 27, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $5.72
Upside: +214.69%
Bright Minds Biosciences
May 21, 2025
Maintains: Buy
Price Target: $80
Current: $27.31
Upside: +192.93%
Xenon Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $55
Current: $32.06
Upside: +71.55%
Mind Medicine (MindMed)
May 9, 2025
Maintains: Buy
Price Target: $20
Current: $7.05
Upside: +183.69%
Centessa Pharmaceuticals
May 8, 2025
Initiates: Buy
Price Target: $30
Current: $12.46
Upside: +140.77%
Praxis Precision Medicines
May 7, 2025
Initiates: Buy
Price Target: $80
Current: $42.90
Upside: +86.48%
Stoke Therapeutics
Mar 19, 2025
Maintains: Buy
Price Target: $24
Current: $11.59
Upside: +107.08%